Tergene Biotech — Aurobindo Pharma Ltd

L24239TG1986PLC015190ActivePublic · Non-govt companyRoC-HyderabadListed
Last updated: 2026-06-08
67
Compliance Health · C · provisional
3 / 4 signals passed

Aurobindo Pharma Ltd is a Public Non-govt company company incorporated in 1986 and based in Telangana, India. Aurobindo Pharma Ltd operates in Hina powder, manufacturing (NIC 24239) with authorized capital of ₹261.15 Cr and paid-up capital of ₹58.59 Cr. For 2025-26, the company reported revenue of ₹11171.72 Cr and profit after tax of ₹2414.80 Cr. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.

Risk FlagsAGM 1831d ago · may be overdue
Revenue (latest FY)
₹11171.72 Cr
2025-26
PAT (latest FY)
₹2414.80 Cr
Margin 21.6%
Open Charges
0
No encumbrances
Active Directors
2
No resignations
Paid-up Capital
₹58.59 Cr
22% of authorized
Filings on Record
0
All current
Incorporated
1986
40 years old
State
Telangana
Sector
Hina powder, manufacturing
NIC 24239
Class
Public
Sub-category
Non-govt company
Authorized Capital
₹261.15 Cr
Paid-up Capital
₹58.59 Cr
22% utilized
Members
Last AGM
26 Aug 2021
1831d ago
Last Balance Sheet
31 Mar 2021
1979d ago
Latest Filing
Registered Email
c***(at)aurobindo.com
Registered Office
PLOT NO.2,MAITHRIVIHAR,BEHIND MAITHRI VANAM AMEERPET, HYDERABAD ANDHRA PRADESH TG 500038 IN
Tergene Biotech
Brand Tergene Biotech · Legal entity Aurobindo Pharma Ltd

Tergene Biotech - Vaccines against bacterial infections.. Acquired by Aurobindo Pharma. Raised funding over 2 rounds from 2 investors.

Total Funding
Latest Round
Revenue
Valuation
Funding Rounds
Employees
Stage
Acquired
HQ
Hyderabad
Founded
2008
Joined to MCA on CIN L24239TG1986PLC015190

Quick facts

Identity · Activity · Auditor · Contact
Registered office
PLOT NO.2,MAITHRIVIHAR,BEHIND MAITHRI VANAM AMEERPET, HYDERABAD ANDHRA PRADESH TG 500038 IN
NIC code
24239
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
c***(at)aurobindo.com
Section
Hina powder, manufacturing
ROC
RoC-Hyderabad
Website
Class · sub-category
Public · Non-govt company
Incorporation · Last AGM
26 Dec 1986 · 26 Aug 2021

Directors

2 activeNo resignations on record

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2526 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 20230dfiled
MGT-7FY2023-2420 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2326 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Aurobindo Pharma Ltd.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
631467094Axis Bank Ltd(Bank)₹2.45 Cr27 Jan 2022Satisfied
156121876State Bank of India(Bank)₹15.22 Cr27 Jan 2021Satisfied
793338871ICICI Bank Ltd(Bank)₹15.56 Cr12 Mar 2020Open
782087962Kotak Mahindra Bank Ltd(Bank)₹20.83 Cr12 Mar 2019Open
536616505ICICI Bank Ltd(Bank)₹4.08 Cr12 Mar 2023Open
352999237Axis Bank Ltd(Bank)₹9.28 Cr27 Jan 2021Open
See registered charges & lenders

Charge IDs, lenders & amounts for Aurobindo Pharma Ltd.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

MCA4 reporting years
Revenue (bars) vs PAT (line) by FY
Revenue PAT
₹0₹10322.25 Cr₹20644.51 Cr₹30966.76 Cr₹4822.66 Cr₹17294.85 Cr₹7.55 L₹29492.15 Cr2015-162020-212023-242025-26
FYRevenuePATNet WorthTotal AssetsEmployees
2025-26
2023-24
2020-21
2015-16

Detailed Financials

4 FYsIncome statement + balance sheet
Line item2025-262023-242020-212015-16
Income statement
Revenue from operations
Other income
Total income
Total expenses
Profit before tax
Profit / (Loss) after tax
Balance sheet
Equity / Net worth
Borrowings
Current liabilities
Total liabilities
Current assets
Cash & equivalents
Total assets
Employees

Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.

Compounded Annual Growth Rate

Derived from multi-FY filings
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue2025-26+17097794.0%+8.0%
Profit after Tax2025-26+40985386.0%+16.0%
Net Worth2020-21+635.0%

Financial Ratios

Profitability · leverage · efficiency
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
2015-16+17.32%+23.78%+13.57%
2020-21+19.67%+69.25%+19.55%+13.42%0.46
2023-24+10.93%-100.00%
2025-26+21.62%+38520548.65%

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters11,86,84,89170.81%
Institutional Investors314,95,2885.67%
Public & Others2462,07,28023.52%
See the full shareholding pattern

Promoter, institutional & public holding for Aurobindo Pharma Ltd.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

4 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
Top quartile · P100
PAT (latest FY)
Top quartile · P100
Employees
Paid-up capital
Top quartile · P100
Compliance Health
96
96
96
Bottom quartile · P0

Top 10 in Hina powder, manufacturing

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Cipla Limited
Maharashtra · Inc 1935
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
Macleods Pharmaceuticals Ltd
Maharashtra · Inc 1989
Paid-up
Revenue
A · 96
06
Cipla Pharmaceuticals Limited
Maharashtra · Inc 2019
Paid-up
Revenue
A · 96
07
Paid-up
Revenue
A · 96
08
Rampex Labs Private Limited
Telangana · Inc 2004
Paid-up
Revenue
A · 96
09
Sanofi India Limited
Maharashtra · Inc 1956
Paid-up
Revenue
A · 96
10
Visakha Pharmacity Limited
Telangana · Inc 2004
Paid-up
Revenue
A · 96

Events & timeline

3Filings, charges, board changes
26 Aug 2021
Girish appointed as Director
30 Aug 2018
Savita appointed as Director
26 Dec 1986
Company incorporated
Aurobindo Pharma Ltd registered with RoC-Hyderabad; year 1986

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Aurobindo Pharma Ltd

When was Aurobindo Pharma Ltd incorporated?
Aurobindo Pharma Ltd was incorporated in 1986 (around 26 Dec 1986). Its CIN is L24239TG1986PLC015190 and it is registered with RoC-Hyderabad.
Where is Aurobindo Pharma Ltd located?
Aurobindo Pharma Ltd is headquartered in Telangana, at: PLOT NO.2,MAITHRIVIHAR,BEHIND MAITHRI VANAM AMEERPET, HYDERABAD ANDHRA PRADESH TG 500038 IN .
What sector does Aurobindo Pharma Ltd operate in?
Aurobindo Pharma Ltd operates in the Hina powder, manufacturing sector (NIC code 24239), classified as Non-govt company.
Who are the directors of Aurobindo Pharma Ltd?
Aurobindo Pharma Ltd has 2 active directors: Girish (Director), Savita (Director).
What is the paid-up capital of Aurobindo Pharma Ltd?
Aurobindo Pharma Ltd has authorized capital of ₹261.15 Cr and paid-up capital of ₹58.59 Cr.
Does Aurobindo Pharma Ltd have any open charges?
Aurobindo Pharma Ltd has no open MCA-registered charges on record.
What is Aurobindo Pharma Ltd's Compliance Health Score?
RegisterKaro's Compliance Health Score for Aurobindo Pharma Ltd is 67/100 (grade C), based on 4 assessable weighted signals across charges, directors, capital, and overall status. 3 of 4 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.